<DOC>
	<DOCNO>NCT01646853</DOCNO>
	<brief_summary>The objective study determine optimal radiation dosage use concurrent chemo-radiotherapy Chinese population . A dose climb experiment carry initiate dose 50Gy conventionally applied Western country .</brief_summary>
	<brief_title>Radiation Dose Study Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil Oesophageal Cancer</brief_title>
	<detailed_description>Esophageal cancer ( EC ) continue major health burden worldwide . The 5-year survival rate esophageal cancer remain less 15 % decade , probably ineffective therapy detection late-stage cancer . Concurrent chemo-radiotherapy establish one viable option therapy patient localize EC follow result landmark trial Radiation Therapy Oncology Group ( RTOG ) 85-01 trial , show significant survival advantage concurrent chemoradiation radiation alone . The use radiochemotherapy cisplatin 5-fluorouracil ( 5-FU ) well-accepted standard definitive treatment esophageal cancer China also demonstrate efficacy good tolerability internationally . The AJCC recommend dose range radiotherapy concurrent therapy 45-50.4Gy . Moreover , ( RTOG ) 85-01 trial also establish 50.4 Gy standard dose radiation administer concurrently chemotherapy . However , appropriate dose radiation fit Chinese remain controversial . Due insufficient evidence EBM , radiation therapist China always prescribe radiation dosage experience . Dosages ( e.g . 60-64Gy ) significantly high international standard commonly use Chinese EC patient lead great likelihood toxicity . Thus Chinese oncologist urgent reach consensus radiation dosage standard treatment local advance EC .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>1 . Biopsyproven squamous cell carcinoma adenocarcinoma thoracic cervical esophagus gastroesophageal junction esophagus , include gastroesophageal junction 2 . Measurable lesion 3 . Age &gt; 18 year 4 . Karnofsky performance score &gt; 70 5 . Life expectancy &gt; 3 month 6 . Adequate bone marrow function ( white blood cell [ WBC ] count ≥ 3.5 109/L , neutrophil count ≥ 2.0 109/L , platelet count ≥ 100 109/L ) , adequate renal function ( creatinine ≤ 2 mg/dL creatinine clearance ≥ 50 mL/min ) , normal liver function ( aspartate aminotransferase alanine aminotransferase less two time upper limit normal , total serum bilirubin ≤ 1.5 mg/dL ) . 1 . Prior systemic chemotherapy EC 2 . Evidence distant metastatic disease 3 . Evidence uncontrolled medical condition ( e.g. , serious infection , grade 4 hypertension , congestive heart failure ) 4 . A history concomitant previous malignancy . 5 . Physical evidence peripheral neuropathy hearing loss</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>